Published in Circulation on January 24, 2011
Atrial Fibrillation Detected by Continuous ECG Monitoring (LOOP) | NCT02036450
Hypertension in Long-Term Care Facilities | NCT03046420
CREATION Health Lifestyle Intervention (CHLI) | NCT03412175
Hypertension Management in Family Practice | NCT03579108
VNS-induced Corticospinal Plasticity | NCT04088565
VNS-supplemented Motor Retraining After Stroke | NCT04088578
Water-only Fasting in the Treatment of Hypertension Patients | NCT04515095
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
The burden of acute heart failure on U.S. emergency departments. JACC Heart Fail (2014) 3.05
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Challenges facing early career academic cardiologists. J Am Coll Cardiol (2014) 2.69
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc (2013) 2.42
Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation (2014) 2.07
Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc (2013) 2.02
Life's Simple 7 and risk of incident stroke: the reasons for geographic and racial differences in stroke study. Stroke (2013) 1.89
Kinase drug discovery--what's next in the field? ACS Chem Biol (2012) 1.84
Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med (2015) 1.82
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest (2014) 1.82
Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation (2014) 1.81
Hypertension-associated expenditures for medication among US adults. Am J Hypertens (2013) 1.74
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
Edward F. Adolph Distinguished Lecture: The remarkable anti-aging effects of aerobic exercise on systemic arteries. J Appl Physiol (1985) (2014) 1.56
Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch Phys Med Rehabil (2014) 1.55
Prevalence of heart failure signs and symptoms in a large primary care population identified through the use of text and data mining of the electronic health record. J Card Fail (2014) 1.55
Acute coronary events. Circulation (2012) 1.54
Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation (2013) 1.48
Myocardial infarction and intramyocardial injection models in swine. Nat Protoc (2012) 1.47
Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46
Sleep-disordered Breathing and Incident Heart Failure in Older Men. Am J Respir Crit Care Med (2016) 1.46
Added sugars in the diet are positively associated with diastolic blood pressure and triglycerides in children. Am J Clin Nutr (2014) 1.43
Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice. Endocrinology (2015) 1.41
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.41
Injectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction. Ann Thorac Surg (2014) 1.40
Automatic identification of heart failure diagnostic criteria, using text analysis of clinical notes from electronic health records. Int J Med Inform (2013) 1.39
The empirical foundations of telemedicine interventions for chronic disease management. Telemed J E Health (2014) 1.34
MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med (2013) 1.34
Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J (2013) 1.31
Status of cardiovascular health among adult Americans in the 50 States and the District of Columbia, 2009. J Am Heart Assoc (2012) 1.28
Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med (2014) 1.27
Quantifying options for reducing coronary heart disease mortality by 2020. Circulation (2013) 1.20
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg (2012) 1.18
Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc (2012) 1.18
Association between usual sodium and potassium intake and blood pressure and hypertension among U.S. adults: NHANES 2005-2010. PLoS One (2013) 1.17
Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg (2011) 1.17
An information extraction framework for cohort identification using electronic health records. AMIA Jt Summits Transl Sci Proc (2013) 1.14
Growth of regional acute stroke systems of care in the United States in the first decade of the 21st century. Stroke (2012) 1.11
Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review. Prev Chronic Dis (2015) 1.11
MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ Res (2014) 1.11
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol (2015) 1.10
Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol (2013) 1.08
Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem (2013) 1.06
Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation (2016) 1.06
Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy. Circ Res (2016) 1.05
Training modalities in robot-mediated upper limb rehabilitation in stroke: a framework for classification based on a systematic review. J Neuroeng Rehabil (2014) 1.04
Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in Mainland China. BMC Public Health (2014) 1.04
Arterial stiffness and hypertension: chicken or egg? Hypertension (2014) 1.04
Barriers and facilitators to self-care in chronic heart failure: a meta-synthesis of qualitative studies. Springerplus (2013) 1.04
Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation (2014) 1.03
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population. Curr Atheroscler Rep (2011) 1.02
Prevalence of the American Heart Association's "ideal cardiovascular health" metrics in a rural, cross-sectional, community-based study: the Heart of New Ulm Project. J Am Heart Assoc (2013) 1.02
More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Aff (Millwood) (2013) 1.01
Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF). Korean Circ J (2017) 1.01
Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program. J Am Heart Assoc (2012) 1.01
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart (2014) 1.01
The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J Neurosurg (2013) 1.00
Aging of the United States population: impact on heart failure. Curr Heart Fail Rep (2012) 1.00
Multi-sensor fusion for enhanced contextual awareness of everyday activities with ubiquitous devices. Sensors (Basel) (2014) 1.00
Medicare payments: how much do chronic conditions matter? Medicare Medicaid Res Rev (2013) 1.00
HDAC-dependent ventricular remodeling. Trends Cardiovasc Med (2013) 1.00
Epigenomics of hypertension. Semin Nephrol (2013) 1.00
Consequences of essential fatty acids. Nutrients (2012) 0.99
Knowledge of heart attack and stroke symptomology: a cross-sectional comparison of rural and non-rural US adults. BMC Public Health (2012) 0.99
HDL cholesterol and bone mineral density: is there a genetic link? Bone (2012) 0.99
Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation. J Clin Oncol (2013) 0.99
Anatomy of success: the top 100 cited scientific reports focused on hypertension research. Hypertension (2013) 0.98
Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail (2014) 0.98
Dyslipidemia and pediatric obesity. Pediatr Clin North Am (2011) 0.97
Better population health through behavior change in adults: a call to action. Circulation (2013) 0.97
Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned. Am J Hypertens (2014) 0.97
Rapid ungated myocardial perfusion cardiovascular magnetic resonance: preliminary diagnostic accuracy. J Cardiovasc Magn Reson (2013) 0.96
Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol (2012) 0.96
Costs of hospitalization for stroke patients aged 18-64 years in the United States. J Stroke Cerebrovasc Dis (2013) 0.95
Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich) (2013) 0.95
Transferability and fine mapping of genome-wide associated loci for lipids in African Americans. BMC Med Genet (2012) 0.95
Poorer physical fitness is associated with reduced structural brain integrity in heart failure. J Neurol Sci (2013) 0.95
Expansion of U.S. emergency medical service routing for stroke care: 2000-2010. West J Emerg Med (2014) 0.94
Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol (2014) 0.94
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol. Drug Des Devel Ther (2013) 0.94
Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications. Exp Biol Med (Maywood) (2013) 0.94
Multimodality image fusion for diagnosing coronary artery disease. J Biomed Res (2013) 0.94
Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy (2016) 0.93
Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations. Clin J Am Soc Nephrol (2013) 0.93
Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012. J Am Heart Assoc (2014) 0.93
Risk factor detection for heart disease by applying text analytics in electronic medical records. J Biomed Inform (2015) 0.93
Incidence of emergency department visits for ST-elevation myocardial infarction in a recent six-year period in the United States. Am J Cardiol (2014) 0.93
Plasma extracellular vesicle protein content for diagnosis and prognosis of global cardiovascular disease. Neth Heart J (2013) 0.92
Acupuncture Point Laterality: Investigation of Acute Effects of Quchi (LI11) in Patients with Hypertension Using Heart Rate Variability. Evid Based Complement Alternat Med (2014) 0.92
Geographic variations in cardiovascular health in the United States: contributions of state- and individual-level factors. J Am Heart Assoc (2015) 0.92
The rise of cardiovascular medicine. Eur Heart J (2012) 0.92
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 12.45
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
The Doctor of Nursing Practice: a national workforce perspective. Nurs Outlook (2011) 10.25
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med (2014) 8.61
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Doctor of nursing practice--MRI or total body scan? Am J Crit Care (2005) 7.95
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45
Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation (2003) 6.95
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA (2006) 6.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA (2010) 6.11
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation (2006) 5.97
Lifetime risks of cardiovascular disease. N Engl J Med (2012) 5.95
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Should the Babinski sign be part of the routine neurologic examination? Neurology (2005) 5.57
Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA (2004) 5.34
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA (2012) 5.17
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12